These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 29808722)

  • 1. RNA sequencing to predict response to TNF-α inhibitors reveals possible mechanism for nonresponse in smokers.
    Cuppen BVJ; Rossato M; Fritsch-Stork RDE; Concepcion AN; Linn-Rasker SP; Bijlsma JWJ; van Laar JM; Lafeber FPJG; Radstake TR;
    Expert Rev Clin Immunol; 2018 Jul; 14(7):623-633. PubMed ID: 29808722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs associated with failure to respond to treatment among patients with rheumatoid arthritis initiating TNFi therapy: a retrospective claims analysis.
    Grabner M; Boytsov NN; Huang Q; Zhang X; Yan T; Curtis JR
    Arthritis Res Ther; 2017 May; 19(1):92. PubMed ID: 28506320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Inflammatory Metabolomic Profile to Predict Response to TNF-α Inhibitors in Rheumatoid Arthritis.
    Cuppen BV; Fu J; van Wietmarschen HA; Harms AC; Koval S; Marijnissen AC; Peeters JJ; Bijlsma JW; Tekstra J; van Laar JM; Hankemeier T; Lafeber FP; van der Greef J;
    PLoS One; 2016; 11(9):e0163087. PubMed ID: 27631111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil biomarkers predict response to therapy with tumor necrosis factor inhibitors in rheumatoid arthritis.
    Wright HL; Cox T; Moots RJ; Edwards SW
    J Leukoc Biol; 2017 Mar; 101(3):785-795. PubMed ID: 27733572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can baseline serum microRNAs predict response to TNF-alpha inhibitors in rheumatoid arthritis?
    Cuppen BV; Rossato M; Fritsch-Stork RD; Concepcion AN; Schenk Y; Bijlsma JW; Radstake TR; Lafeber FP;
    Arthritis Res Ther; 2016 Aug; 18(1):189. PubMed ID: 27558398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy.
    Wright HL; Thomas HB; Moots RJ; Edwards SW
    Rheumatology (Oxford); 2015 Jan; 54(1):188-93. PubMed ID: 25125592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential gene expression profiles may differentiate responder and nonresponder patients with rheumatoid arthritis for methotrexate (MTX) monotherapy and MTX plus tumor necrosis factor inhibitor combined therapy.
    Oliveira RD; Fontana V; Junta CM; Marques MM; Macedo C; Rassi DM; Passos GA; Donadi EA; Louzada-Junior P
    J Rheumatol; 2012 Aug; 39(8):1524-32. PubMed ID: 22753658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early prediction of clinical response to anti-TNF treatment using multi-omics and machine learning in rheumatoid arthritis.
    Yoosuf N; Maciejewski M; Ziemek D; Jelinsky SA; Folkersen L; Müller M; Sahlström P; Vivar N; Catrina A; Berg L; Klareskog L; Padyukov L; Brynedal B
    Rheumatology (Oxford); 2022 Apr; 61(4):1680-1689. PubMed ID: 34175943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in the metabolome in response to disease activity of rheumatoid arthritis.
    Tatar Z; Migne C; Petera M; Gaudin P; Lequerre T; Marotte H; Tebib J; Pujos Guillot E; Soubrier M
    BMC Musculoskelet Disord; 2016 Aug; 17(1):353. PubMed ID: 27549132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics to predict the response to tumour necrosis factor-α inhibitors in rheumatoid arthritis using a supervised cluster-analysis based protein score.
    Cuppen B; Fritsch-Stork R; Eekhout I; de Jager W; Marijnissen AC; Bijlsma J; Custers M; van Laar JM; Lafeber F; Welsing P;
    Scand J Rheumatol; 2018 Jan; 47(1):12-21. PubMed ID: 28650254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetic risk score composed of rheumatoid arthritis risk alleles, HLA-DRB1 haplotypes, and response to TNFi therapy - results from a Swedish cohort study.
    Jiang X; Askling J; Saevarsdottir S; Padyukov L; Alfredsson L; Viatte S; Frisell T
    Arthritis Res Ther; 2016 Dec; 18(1):288. PubMed ID: 27912794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study.
    Talotta R; Berzi A; Atzeni F; Dell'Acqua D; Sarzi Puttini P; Trabattoni D
    Reumatismo; 2016 Sep; 68(2):83-9. PubMed ID: 27608796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling in peripheral blood cells of patients with rheumatoid arthritis in response to anti-TNF-alpha treatments.
    Meugnier E; Coury F; Tebib J; Ferraro-Peyret C; Rome S; Bienvenu J; Vidal H; Sibilia J; Fabien N
    Physiol Genomics; 2011 Apr; 43(7):365-71. PubMed ID: 21266503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab.
    Sekiguchi N; Kawauchi S; Furuya T; Inaba N; Matsuda K; Ando S; Ogasawara M; Aburatani H; Kameda H; Amano K; Abe T; Ito S; Takeuchi T
    Rheumatology (Oxford); 2008 Jun; 47(6):780-8. PubMed ID: 18388148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD11c as a transcriptional biomarker to predict response to anti-TNF monotherapy with adalimumab in patients with rheumatoid arthritis.
    Stuhlmüller B; Häupl T; Hernandez MM; Grützkau A; Kuban RJ; Tandon N; Voss JW; Salfeld J; Kinne RW; Burmester GR
    Clin Pharmacol Ther; 2010 Mar; 87(3):311-21. PubMed ID: 20032971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug.
    Söderlin MK; Petersson IF; Geborek P
    Scand J Rheumatol; 2012 Feb; 41(1):1-9. PubMed ID: 22118371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High serum level of haptoglobin is associated with the response of 12 weeks methotrexate therapy in recent-onset rheumatoid arthritis patients.
    Tan W; Wang F; Guo D; Ke Y; Shen Y; Lv C; Zhang M
    Int J Rheum Dis; 2016 May; 19(5):482-9. PubMed ID: 24863583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis.
    Lequerré T; Gauthier-Jauneau AC; Bansard C; Derambure C; Hiron M; Vittecoq O; Daveau M; Mejjad O; Daragon A; Tron F; Le Loët X; Salier JP
    Arthritis Res Ther; 2006; 8(4):R105. PubMed ID: 16817978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis.
    Oladapo A; Barner JC; Lawson KA; Novak S; Rascati KL; Richards KM; Harrison DJ
    J Manag Care Spec Pharm; 2014 Jul; 20(7):657-67. PubMed ID: 24967519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.